Koninklijke Philips NV

Headquartered in Amsterdam in the Netherlands, Koninklijke Philips is a health technology company that develops diagnostics and imaging equipment. The company was established in 1891 and operates in more than 100 countries across the globe. In its commitment to driving a sustainable business, the organisation plotted three development goals: promoting the health of all people, addressing sustainability in consumption and production, and actively seeking to remedy climate change. In 2020, Koninklijke Philips received recognition for its attempts to curb climate change. Koninklijke Philips is listed on the NYSE, trading its stock using the ticker PHG. The company announced intentions to acquire BioTelemetry, a US cardiac monitoring and diagnostics outfit, in December 2020. This acquisition is worth $2.8bn and will aid the company’s remote care products operations. Koninklijke Philips has three operating divisions: Diagnosis and Treatment, Connected Care, and Personal Health. Its diagnostics and imaging offerings include computed tomography, advanced molecular imaging, diagnostic X-rays, and integrated clinical solutions. Koninklijke Philips also provides digital cloud-based platforms for healthcare providers and healthcare users. These platforms provide information on products, services, and devices. Interested in this instrument? Add it to your eToro watchlist and receive news and updates on PHG share price trends and developments.